Borderline Personality Disorder
Meetings- From the National Institute of Mental Health (NIMH)
Jim Breiling, Ph.D.
National Institute of Mental Health
6101 Executive Blvd., Room 6-179
Bethesda, MD 20892-9651
(Express or Courier Service: Rockville, MD 20852)
E-mail: jbreilin@mail.nih.gov
Voice: 301-443-3527
Fax: 301-443-4611
Borderline Personality Disorder Meetings
June 15, 2004
The interest among researchers in attending the Borderline
Personality Disorder treatment think tank has been unexpectedly strong -- and because so many of those who wanted to come
are bright and able junior researchers who are our future, this interest has
been most welcome, but we have now reached (indeed, slightly exceeded)
capacity. So, except for two special junior researchers who have been in
communication with me about attending if they can arrange support, this
meeting is closed to new registrations. We will be working with those
attending the think tank to facilitate the dissemination of presentations
and discussions there to the larger BPD research community.
Two Borderline Personality Research Foundation - NIMH meetings are in the
works for early in 2005. One will address issues around the phenotype. The
other will be a launch pad for a mentoring program for junior investigators
who are viable applicants for NIMH grants for BPD research.. (With benefit
of the ready assistance of a cadre of senior BPD treatment researchers, we
will be launching this mentoring effort for search at the think tank.)
June 3, 2004
NIMH sponsors the annual New Clinical Drug Evaluation Unit (NCDEU) meeting.
Borderline PD has not yet made it as an explicit focus at NCDEU, but two
treatment development sessions yesterday at this year's NCDEU meeting in
Phoenix, Arizona, are close and relevant. These two sessions (see below)
focused on impulsivity; one with a clinical treatment focus, the other
drawing on basic research.
Emil Coccaro, who is well known to the borderline pd research community, was
a presenter. James Blair of the NIMH intramural program, who presented at
the second New Directions in Borderline Personality Research at the University of Minnesota, was also a presenter. William Potter of Eli Lilly
was a participant in both panels.
Pharmacological treatment opportunities and issues will be one of the focuses at NIMH's international think tank July 8- 11 for the more effective
treatment of borderline pd.
-- Jim Breiling
Thursday, June 3, 2004
Treatment Development Session 5
9:00 a.m. - 12:00 p.m. McArthur Salon 4
Impulsivity and Aggression as Clinical Treatment Targets
Chairs: Melissa DelBello, M.D., University of Cincinnati
Jeffrey A. Mattes, M.D., Psychopharmacology Research of Princeton
9:00 a.m. - 9:25 a.m. Impulsivity and Aggression across the Spectrum of
Neuropsyhiatric Disorders
Emil Coccaro, M.D., University of Chicago
9:25 a.m. - 9:50 a.m. Neurobiology of Impulsivity in Children and Adolescents
James Blair, Ph.D., National Institute of Mental Health
9:50 a.m. - 10:15 a.m. Phenomenology and Overlap of Impulsivity and Aggression in Juvenile Bipolar Disorder, ADHD and Related Impulsivity
Spectrum Disorders of Children and Adolescents
Janet Wozniak, M.D., Massachusetts General Hospital/Harvard Medical School
10:15 a.m. - 10:40 a.m. Measurement and Ratings of Impulsivity and Aggression in Children with
ADHD, Bipolar and Related Disorders
Melissa DelBello, M.D.
10:40 a.m. - 11:05 a.m. Diagnostic and Methodologic Advances in Evaluating
Medication for Adult Intermittent Explosive Disorder
Jeffrey A. Mattes, M.D.
11:05 a.m. - 11:30 a.m. Industry Perspective on Treatment Development for
Impulsive Aggression
William Z. Potter, M.D., Ph.D., Eli Lilly and Company
11:30 a.m. - 11:45 a.m. Discussants
Eric Hollander, M.D., Mt. Sinai School of Medicine
Thomas P. Laughren, M.D., Food and Drug Administration
11:45 a.m. - 12:00 p.m. General Discussion
******************************************************************
Treatment Development Session 6
2:15 p.m. - 4:15 p.m. McArthur Salon 4
Models and Objective Measures Relevant to Impulsivity in Mental Disorders
Chair: Lois Winsky, Ph.D., National Institute of Mental Health
2:15 p.m. - 2:45 p.m. Preclinical Animal Models of Impulsivity: Strategies
and Challenges
John L. Evenden, Ph.D., AstraZeneca Pharmaceuticals
2:45 p.m. - 3:15 p.m. Behavioral and Physiological Measures and Models of
Reward: Implications for Understanding Impulsivity
Brian Knutson, Ph.D., Stanford University
3:15 p.m. - 3:45 p.m. Comparative Assessment of Impulsive Behavior in Clinical and Animal Studies
Harriet de Wit, Ph.D., University of Chicago
3:45 p.m. - 4:15 p.m. Discussant
William Z. Potter, M.D., Ph.D., Eli Lilly and Company
Visit
MH Matters for information
and articles. Get
help to find
a therapist or list
your practice; and Psych
Forums for message boards on a variety of MH topics.
Sponsors:
Aphrodite's Love Poetry ¦ Make
Money on the Internet
|
